(Q46335530)

English

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

1 reference

based on heuristic

inferred from title

1

object named as

Shin Nishio

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

Toshiharu Kamura

9

object named as

Toshiharu Kamura

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

3

object named as

Koji Matsumoto

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

Takahiro Kasamatsu

10

object named as

Takahiro Kasamatsu

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

Chikako Shimizu

7

object named as

Chikako Shimizu

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

Yasuhiro Fujiwara

11

object named as

Yasuhiro Fujiwara

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

5

object named as

Kan Yonemori

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

8

object named as

Masashi Ando

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

Noriyuki Katsumata

2

object named as

Noriyuki Katsumata

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

author name string

Hiroshi Tanabe

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

Tsutomu Kouno

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

publication date

1 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

135

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

551-557

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

https://scigraph.springernature.com/pub.10.1007/s00432-008-0488-x

0 references

Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials

1 reference

https://api.crossref.org/works/10.1007%2FS00432-008-0488-X

21 January 2018

Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Developmental chemotherapy and management of recurrent ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that a "treatment-free interval of less than 6 months" does not equate with clinically defined platinum resistance in ovarian cancer or primary peritoneal carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"Recurrence within 6 months of platinum therapy": an adequate definition of "platinum-refractory" ovarian cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and determinants of response to third-line chemotherapy in sensitive recurrent ovarian cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment preferences in recurrent ovarian cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for recurrent epithelial ovarian cancer previously treated with platinum--a systematic review of the evidence from randomized trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients [seecomments]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-line chemotherapy for recurrent carcinoma of the ovary.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A cost-effectiveness analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical features of hypersensitivity reactions to carboplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2001

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Third-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830625

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-008-0488-X

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18830625

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46335530&oldid=2105781712"